Skip to content
LexBuild

Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin

---
identifier: "/us/fr/2014-08010"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin"
title_number: 0
title_name: "Federal Register"
section_number: "2014-08010"
section_name: "Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin"
positive_law: false
currency: "2014-04-10"
last_updated: "2014-04-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2014-08010"
document_type: "rule"
publication_date: "2014-04-10"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 510"
  - "21 CFR Part 558"
fr_citation: "79 FR 19816"
fr_volume: 79
docket_ids:
  - "Docket No. FDA-2014-N-0002"
effective_date: "2014-04-21"
fr_action: "Notification of withdrawal."
---

#  Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notification of withdrawal.

**SUMMARY:**

The Food and Drug Administration (FDA) is withdrawing approval of 19 new animal drug applications (NADAs) for certain Type A medicated articles and Type B medicated feeds. This action is being taken at the sponsors' request because these products are no longer manufactured or marketed.

**DATES:**

Withdrawal of approval is effective April 21, 2014.

**FOR FURTHER INFORMATION CONTACT:**

John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

The following 5 sponsors have requested that FDA withdraw approval of the 19 NADAs listed in the following tables because the products are no longer manufactured or marketed:

• ADM Alliance Nutrition, Inc., 1000 North 30th St., Quincy, IL 62305-3115:

| NADA | Product name |
| --- | --- |
| 091-582 | Gilt Edge TYLAN (tylosin phosphate) Mix. |
| 108-484 | HFA Tylosin-10 Plus Sulfa (tylosin phosphate and sulfamethazine). |
| 110-045 | Good Life TYLAN 10 (tylosin phosphate) Premix. |
| 110-439 | HFA HYGROMIX 0.48 (hygromycin B) Medicated Premix. |
| 128-411 | TYLAN 5 Sulfa (tylosin phosphate and sulfamethazine) Premix. |

• Micro Beef Technologies LTD, P.O. Box 9262, Amarillo, TX 79105:

| NADA | Product name |
| --- | --- |
| 138-187 | TYLAN 40 or 100 (tylosin phosphate). |

• Ridley USA, Inc. d/b/a Ridley Feed Ingredients, 1609 1st Ave., P.O. Box 110, Mendota, IL 61342:

| NADA | Product name |
| --- | --- |
| 099-468 | Waynextra for Swine (tylosin phosphate). |
| 131-958 | TYLAN Sulfa-G (tylosin phosphate and sulfamethazine). |
| 132-136 | Ban-A-Worm II (pyrantel tartrate). |

• Provimi North America, Inc., 6531 State Rte. 503, Lewisburg, OH 45338:

| NADA | Proprietary name |
| --- | --- |
| 103-089 | TYLAN 5, 10, 20, or 40 (tylosin phosphate). |
| 118-814 | WORM-BAN 5 or 10 (pyrantel tartrate). |
| 127-508 | HYGROMIX 0.6 (hygromycin B). |
| 131-413 | FLAVOMYCIN 0.4 or 2 (bambermycins). |
| 133-333 | STAFAC 10 (virginiamycin). |

• Virbac AH, Inc., 3200 Meacham Blvd., Fort Worth, TX 76137:

| NADA | Proprietary name |
| --- | --- |
| 013-214 | PURINA HYGROMIX (hygromycin B) for Swine. |
| 042-660 | PURINA Pork-Plus (tylosin phosphate and sulfamethazine). |
| 043-387 | PURINA Hog Plus II (tylosin phosphate). |
| 099-767 | PURINA TYLAN 40 (tylosin) Plus Sulfamethazine. |
| 132-574 | PURINA Check-R-Ton Ll (lincomycin hydrochloride). |

[^1] The NADAs listed were identified as being affected by guidance for industry (GFI) #213, “New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions With GFI #209”, December 2013.

Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116 *Notice of withdrawal of approval of application* (21 CFR 514.116), notice is given that approval of the NADAs listed in this document, and all supplements and amendments thereto, is hereby withdrawn.

Elsewhere in this issue of the *Federal Register,* FDA is amending the animal drug regulations to reflect the voluntary withdrawal of approval of these applications.

Dated: April 4, 2014.

Bernadette Dunham,

Director, Center for Veterinary Medicine.